
David Collister
@turbo_dc
Followers
796
Following
4K
Media
29
Statuses
981
MD, PhD. Kidney doctor interested in clinical trials and uremic symptoms. Came for the science, stayed for the memes he/him
Edmonton, Alberta
Joined May 2013
Was able to reschedule my clinic to later in the week and book my own flight on competitor airline as >24 hours initial departure/cancellation still zero communication re: a solution to get me home. Grateful to be in the EU where there are passenger rights. @AirCanada is garbage.
1
0
1
RT @UAlberta_DoM: Congratulations to the Department of Medicine Class of '25 who are graduating today! Read more about seven of our graduat….
0
4
0
RT @ISNkidneycare: ➡️ The role of sex and gender in acute kidney injury—consensus statements from the 33rd Acute Disease Quality Initiative….
0
1
0
RT @cansolveckd: The @kidneycheck program provides early kidney disease screening for Indigenous communities in rural and remote areas, hel….
0
4
0
Come join us in Vancouver for virtually to learn about what trials are available for patients with kidney disease in Canada. @CSNSCN.
CNTN Research Symposium registration is now open! This is a great opportunity to learn about what CNTN has been up to, where it is going, and how to get involved. If you would like to present, contact Omo Enilama at oenilama@cansolveckd.ca .Register:
0
1
5
RT @Kidney_Int: The Role of Sex and Gender in #AcuteKidneyInjury - Consensus Statements from the 33rd Acute Disease Quality Initiative. htt….
0
8
0
Does you center do intraoperative PTH monitoring for secondary/tertiary parathyroidectomy? @Ask_Renal #askrenal.
1
3
3
At how many hours of home HD q weekly would you rx 2 tablets of replavite instead of only 1? @Ask_Renal #ask_renal.
1
2
2
Come talk cannabis and itch with me at Poster 1192. May be hitting up a dispensary later. 😂.@ASNKidney @CNTN_RCEN @CIHR_IRSC
0
1
12
RT @GuyattGH: Clinical trialists often use run-in periods to identify non-adherers who they don’t enrol thus ensuring maximum adherence in….
pubmed.ncbi.nlm.nih.gov
ClinicalTrials.gov Identifier: NCT03020303.
0
5
0
@Roche @GSK @KristinKClemens @kidneycanada Thank you @CJKHD and @CMClase for your journal’s portable and kind review policies 14/14.
1
0
2
@Roche @GSK However, it is exciting to see work done in this area including the PREFERRED-1 trial (denosumab vs usual care) by @KristinKClemens funded by @kidneycanada and supported by
1
0
1